Manufacturer record
Om Biomedic Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
11 batches manufactured by Om Biomedic Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between January 2020 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: IA26-64, Oxytocin Injection IP (exp Dec 2027). RDTL, Guwahati (CDSCO lab) found it not of standard quality: The sample does not comply I.P. 2022 with respect to the test for "Bacterial Endotoxins and Sterility" of Oxytocin Injections. Listed in the September 2026 alert.
Records by type
11 records linked to Om Biomedic Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Oxytocin Injection IP | Batch IA26-64Mfg Jan 2026 · Exp Dec 2027 | The sample does not comply I.P. 2022 with respect to the test for "Bacterial Endotoxins and Sterility" of Oxytocin Injections.Sterility | RDTL, GuwahatiCDSCO lab | Sep 2026 |
| Amlodipine Besylate Tablets IP 5 mg. | Batch TA25-30Mfg Jan 2025 · Exp Dec 2026 | The sample does not conform to I.P. w.r.t. the tests for AssayAssay | SDTL, AssamState lab | Mar 2026 |
| Codeine Phosphate Syrup IP 15 mg/5ml | Batch LE24-57Mfg May 2024 · Exp Apr 2026 | Assay of Codeine PhosphateAssay | Drugs Testing Laboratory,Shillong,MeghalayaState lab | Aug 2025 |
| Dicyclomine Hydrochloride Tablets IP 10 mg | Batch TK24-08Mfg Nov 2024 · Exp Oct 2026 | DescriptionDescription | RDTL, GuwahatiCDSCO lab | May 2025 |
| Dexamethasone Oral Solution USP 0.5mg per 5ml | Batch LG24-29Mfg Jul 2024 · Exp Jun 2026 | AssayAssay | RDTL, GuwahatiCDSCO lab | Mar 2025 |
| DRIED FERROUS SULPHATE & FOLIC ACID TABLETS IP | Batch TC21-74Mfg Mar 2021 · Exp Feb 2023 | DescriptionDescription | RDTL GuwahatiState lab | Oct 2022 |
| Dried Ferrous Sulphate & Folic Acid Tablets IP | Batch TE22-24Mfg May 2022 · Exp Apr 2024 | DescriptionDescription | RDTL GuwahatiState lab | Sep 2022 |
| Amlodipine Tablets IP | Batch TL20-25Mfg Dec 2020 · Exp Nov 2022 | AssayAssay | RDTL GuwahatiState lab | Apr 2022 |
| Pantoprazole Gastro- Resistant Tablets I.P. | Batch TA21-11Mfg Jan 2021 · Exp Dec 2022 | DissolutionDissolution | RDTL GuwahatiState lab | Jan 2022 |
| Pantoprazole Gastro Resistant Tablets IP | Batch TD20-16Mfg Apr 2020 · Exp Mar 2022 | Dissolution (Buffer stage)Dissolution | RDTL GuwahatiState lab | Dec 2021 |
| Fluconazole Tablets | Batch TOH-02Mfg Apr 2019 · Exp Mar 2021 | Uniformity of DispersionUniformity of weight/content | CDL KolkataCDSCO lab | Jan 2020 |
Batches reported as suspected spurious under this label
CDSCO's spurious-drug alerts list batches that purport to be made by a company but are suspected counterfeits. The labelled manufacturer's reply is shown where CDSCO published it.
| Product | Batch | Reported by | Firm's reply | Alert |
|---|---|---|---|---|
| Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets Zerodol-SP | FND072001BH | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Dec 2025 |
| Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets ZERODOL-SP TABLETS | FND0725001BH | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Dec 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.